These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30846768)

  • 1. IP-10 dried blood spots assay monitoring treatment efficacy in extrapulmonary tuberculosis in a low-resource setting.
    Hoel IM; Jørstad MD; Marijani M; Ruhwald M; Mustafa T; Dyrhol-Riise AM
    Sci Rep; 2019 Mar; 9(1):3871. PubMed ID: 30846768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IP-10 measured by Dry Plasma Spots as biomarker for therapy responses in Mycobacterium Tuberculosis infection.
    Tonby K; Ruhwald M; Kvale D; Dyrhol-Riise AM
    Sci Rep; 2015 Mar; 5():9223. PubMed ID: 25783975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dried plasma spots in the diagnosis of tuberculosis: IP-10 release assay on filter paper.
    Aabye MG; Latorre I; Diaz J; Maldonado J; Mialdea I; Eugen-Olsen J; Ravn P; Dominguez J; Ruhwald M
    Eur Respir J; 2013 Aug; 42(2):495-503. PubMed ID: 23349445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma interferon-γ-inducible protein 10 (IP-10) levels correlate with disease severity and paradoxical reactions in extrapulmonary tuberculosis.
    Suárez I; Rohr S; Stecher M; Lehmann C; Winter S; Jung N; Priesner V; Berger M; Wyen C; Augustin M; Malin JJ; Fischer J; Horn C; Neuhann F; Püsken M; Plum G; Fätkenheuer G; Rybniker J
    Infection; 2021 Jun; 49(3):437-445. PubMed ID: 33140838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of host biomarkers from dried blood spots for monitoring treatment response in extrapulmonary tuberculosis.
    Khalid S; Ambreen A; Khaliq A; Ullah H; Mustafa M; Mustafa T
    Sci Rep; 2023 Jan; 13(1):599. PubMed ID: 36635313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a one-step probe based molecular assay for rapid immunodiagnosis of infection with M. tuberculosis using dried blood spots.
    Blauenfeldt T; Heyckendorf J; Graff Jensen S; Lange C; Drabe C; Hermansen TS; de Thurah L; Lillebaek T; Eugen-Olsen J; Seersholm N; Hoff S; Bonde J; Ruhwald M
    PLoS One; 2014; 9(9):e105628. PubMed ID: 25184553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of IP-10 detection in dried plasma spots for latent tuberculosis infection diagnosis in contacts via mail.
    Villar-Hernández R; Latorre I; De Souza-Galvão ML; Jiménez MA; Ruiz-Manzano J; Pilarte J; García-García E; Muriel-Moreno B; Cantos A; Altet N; Millet JP; González-Díaz Y; Molina-Pinargote I; Prat C; Ruhwald M; Domínguez J
    Sci Rep; 2019 Mar; 9(1):3943. PubMed ID: 30850687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the performance of Abbott m2000 and Roche COBAS Ampliprep/COBAS Taqman assays for HIV-1 viral load determination using dried blood spots and dried plasma spots in Kenya.
    Zeh C; Ndiege K; Inzaule S; Achieng R; Williamson J; Chih-Wei Chang J; Ellenberger D; Nkengasong J
    PLoS One; 2017; 12(6):e0179316. PubMed ID: 28622370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy.
    Wergeland I; Pullar N; Assmus J; Ueland T; Tonby K; Feruglio S; Kvale D; Damås JK; Aukrust P; Mollnes TE; Dyrhol-Riise AM
    J Infect; 2015 Apr; 70(4):381-91. PubMed ID: 25597826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple method to quantitate IP-10 in dried blood and plasma spots.
    Aabye MG; Eugen-Olsen J; Werlinrud AM; Holm LL; Tuuminen T; Ravn P; Ruhwald M
    PLoS One; 2012; 7(6):e39228. PubMed ID: 22761744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood and urine inducible protein 10 as potential markers of disease activity.
    Petrone L; Cannas A; Vanini V; Cuzzi G; Aloi F; Nsubuga M; Sserunkuma J; Nazziwa RA; Jugheli L; Lukindo T; Girardi E; Antinori A; Pucci L; Reither K; Goletti D
    Int J Tuberc Lung Dis; 2016 Nov; 20(11):1554-1561. PubMed ID: 27776600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IP-10 can be measured in dried plasma spots in patients with chronic hepatitis C infection.
    Ruhwald M; Andersen ES; Christensen PB; Moessner BK; Weis N
    PLoS One; 2012; 7(9):e45181. PubMed ID: 23024806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine Kinetics in the First Week of Tuberculosis Therapy as a Tool to Confirm a Clinical Diagnosis and Guide Therapy.
    den Hertog AL; Montero-Martín M; Saunders RL; Blakiston M; Menting S; Sherchand JB; Lawson L; Oladimeji O; Abdurrahman ST; Cuevas LE; Anthony RM
    PLoS One; 2015; 10(6):e0129552. PubMed ID: 26115421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and clinical outcomes of extrapulmonary tuberculosis in antiretroviral therapy programmes in low- and middle-income countries: a multicohort study.
    Zürcher K; Ballif M; Kiertiburanakul S; Chenal H; Yotebieng M; Grinsztejn B; Michael D; Sterling TR; Ngonyani KM; Mandalakas AM; Egger M; Pettit AC; Fenner L;
    J Int AIDS Soc; 2019 Sep; 22(9):e25392. PubMed ID: 31507083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IP-10 and RANTES as biomarkers for pulmonary tuberculosis diagnosis and monitoring.
    Zhao Y; Yang X; Zhang X; Yu Q; Zhao P; Wang J; Duan C; Li J; Johnson H; Feng X; Zhang H
    Tuberculosis (Edinb); 2018 Jul; 111():45-53. PubMed ID: 30029914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between HIV-1 viral load quantification in plasma, dried blood spots, and dried plasma spots using the Roche COBAS Taqman assay.
    Andreotti M; Pirillo M; Guidotti G; Ceffa S; Paturzo G; Germano P; Luhanga R; Chimwaza D; Mancini MG; Marazzi MC; Vella S; Palombi L; Giuliano M
    J Clin Virol; 2010 Jan; 47(1):4-7. PubMed ID: 19962936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcome of extrapulmonary tuberculosis under Revised National Tuberculosis Control Programme.
    Cherian JJ; Lobo I; Sukhlecha A; Chawan U; Kshirsagar NA; Nair BL; Sawardekar L
    Indian J Tuberc; 2017 Apr; 64(2):104-108. PubMed ID: 28410692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study.
    Alsleben N; Ruhwald M; Rüssmann H; Marx FM; Wahn U; Magdorf K
    Scand J Infect Dis; 2012 Apr; 44(4):256-62. PubMed ID: 22103555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the Xpert MTB/RIF Ultra assay on rapid diagnosis of extrapulmonary tuberculosis.
    Wu X; Tan G; Gao R; Yao L; Bi D; Guo Y; Yu F; Fan L
    Int J Infect Dis; 2019 Apr; 81():91-96. PubMed ID: 30738907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IP-10 Kinetics in the First Week of Therapy are Strongly Associated with Bacteriological Confirmation of Tuberculosis Diagnosis in HIV-Infected Patients.
    García-Basteiro AL; Mambuque E; den Hertog A; Saavedra B; Cuamba I; Oliveras L; Blanco S; Bulo H; Brew J; Cuevas LE; Cobelens F; Nhabomba A; Anthony R
    Sci Rep; 2017 Oct; 7(1):14302. PubMed ID: 29084992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.